SUBSCRIBE
SUBSCRIBE

European Medicines Evaluation Agency Reviews Roche’s Avastin In Breast Cancer

September 24, 2010 | 
1 min read

ZURICH, Sept 24 (Reuters) - European healthcare regulators are reviewing the benefits of using Roche’s (ROG.VX) top-selling Avastin drug in breast cancer, in the light of fresh clinical trial results.

Europe
Roche
MORE ON THIS TOPIC
Weigh scales on pink background, top view with space for text. Overweight concept
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
February 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s Tariffs Threaten Big Pharma With Higher Costs and Slimmer Margins
February 3, 2025
 · 
3 min read
 · 
Tristan Manalac
Biogen’s headquarters in Massachusetts
Layoffs
Biogen Trims Research Workforce, Higher-Dose SMA Drug Accepted for Regulatory Review
January 23, 2025
 · 
3 min read
 · 
Tristan Manalac
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
Manufacturing
Samsung Biologics Continues Mega-Deal Streak With $1.4B European Contract
January 23, 2025
 · 
2 min read
 · 
Tristan Manalac